FDA accepts Ascendis Pharma’s TransCon hGH BLA for pediatric GHD

Ascendis Pharma, a Danish biopharma company, said that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for TransCon hGH ... Read More